Nuala Moran

Head of Innovative Medicines Initiatives argues that the project’s technologies, knowledge and networks came together in the crisis. The successor programme must sustain these achievements and build on them

The COVID-19 crisis has hammered home the extent of EU dependence on Chinese and US digital technologies. To turn the tide, the emphasis must be on frontier research and translating the outputs to products and jobs

The flaws in Europe’s healthcare systems have been cruelly exposed by COVID-19, experts tell a Science|Business Webcast conference. As lockdowns begin to lift, critical gaps and fault lines must be addressed to increase preparedness for the next big shock 

Talent mobility can involve crossing borders – but there are lots of other ways the EU could promote movement of smart people, a Science|Business conference heard.  Targeted measures are needed in Horizon Europe

Insistence on excellence in its grant selections has made the European Research Council a leading global brand. But there are lots of ways to define what excellence is, a Science|Business conference hears.

As Austria’s EU Presidency approaches, health official Clemens Auer says it’s time to stop the pilots and let digital health fly

Employees are lukewarm on new locations and a slow-down in work rate will mean less income. In the best case scenario Europe’s drugs regulator will take 2-3 years to get back to speed after leaving London.